{"DataElement":{"publicId":"6771219","version":"1","preferredName":"Breast DCIS Nuclear Grade Category","preferredDefinition":"The nuclear grade category used to classify Breast DCIS.","longName":"DCIS_NUC_GRAD_CAT","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"6771092","version":"1","preferredName":"Breast Ductal Carcinoma In Situ Nuclear Grade","preferredDefinition":"A carcinoma entirely confined to the mammary ducts.  It is also known as DCIS.  There is no evidence of invasion of the basement membrane.  Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS._An evaluation of the size and shape of the nucleus in tumor cells and the percentage of tumor cells that are in the process of dividing or growing. Cancers with low nuclear grade grow and spread less quickly than cancers with high nuclear grade.","longName":"2413053v1.0:2673287v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"2413053","version":"1","preferredName":"DCIS","preferredDefinition":"Ductal carcinoma in situ (DCIS) is a carcinoma entirely confined to the mammary ducts.  There is no evidence of invasion of the basement membrane.  Currently, DCIS is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS. --2002","longName":"C2924","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"01D4D496-BCED-3A9F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-30","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-09-30","modifiedBy":"ONEDATA","dateModified":"2005-09-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2673287","version":"1","preferredName":"Nuclear Grade","preferredDefinition":"An evaluation of the size and shape of the nucleus in tumor cells and the percentage of tumor cells that are in the process of dividing or growing. Cancers with low nuclear grade grow and spread less quickly than cancers with high nuclear grade.","longName":"C18513","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nuclear Grade","conceptCode":"C18513","definition":"An evaluation of the size and shape of the nucleus in tumor cells and the percentage of tumor cells that are in the process of dividing or growing. Cancers with low nuclear grade grow and spread less quickly than cancers with high nuclear grade.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3820C894-5B12-31EA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-20","endDate":null,"createdBy":"UMLLOADER_BCR","dateCreated":"2007-08-20","modifiedBy":"ONEDATA","dateModified":"2007-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A1D03F3-E0FD-0C36-E053-F662850A3EB1","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeDescription":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-30-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6771218","version":"1","preferredName":"DCIS Nuclear Grade Category","preferredDefinition":"A carcinoma entirely confined to the mammary ducts.  It is also known as DCIS.  There is no evidence of invasion of the basement membrane.  Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS._An evaluation of the size and shape of the nucleus in tumor cells and the percentage of tumor cells that are in the process of dividing or growing. Cancers with low nuclear grade grow and spread less quickly than cancers with high nuclear grade._A grouping of items based on some commonality or by user defined characteristics.","longName":"6771218v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Data not available","valueDescription":"Source Data Not Available","ValueMeaning":{"publicId":"4842575","version":"1","preferredName":"Source Data Not Available","longName":"4842575","preferredDefinition":"Data from an original source is not present, accessible or ready for use or service.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Source Data Not Available","conceptCode":"C67329","definition":"Data from an original source is not present, accessible or ready for use or service.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"173BF844-9709-E098-E050-BB89AD431F3E","latestVersionIndicator":"Yes","beginDate":"2015-05-29","endDate":null,"createdBy":"LEEW","dateCreated":"2015-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4E6B4B-4335-317B-E053-F662850A1954","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682944","version":"1","preferredName":"Unknown","longName":"5682944","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9AE5-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"GDEEN","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B4E6B4B-433F-317B-E053-F662850A1954","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"ONEDATA","dateModified":"2019-06-14","deletedIndicator":"No"},{"value":"Intermediate","valueDescription":"Intermediate Grade Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"3249016","version":"1","preferredName":"Intermediate Grade Ductal Breast Carcinoma In Situ","longName":"3249016","preferredDefinition":"Ductal breast carcinoma in situ characterized by the presence of monomorphic neoplastic cells that form cribriform, micropapillary, or solid patterns. Intraluminal necrosis is present in some ducts. Ducts that contain neoplastic cells with occasional nucleoli and coarse chromatin may also be present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ, Intermediate Grade","conceptCode":"C9456","definition":"Breast ductal carcinoma in situ characterized by the presence of monomorphic neoplastic cells that form cribriform, micropapillary, or solid patterns. Intraluminal necrosis is present in some ducts. Ducts that contain neoplastic cells with occasional nucleoli and coarse chromatin may also be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-15C8-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A19C823-6F18-799A-E053-F662850A6C0A","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"ONEDATA","dateModified":"2019-05-30","deletedIndicator":"No"},{"value":"Low","valueDescription":"Low Grade Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"3249014","version":"1","preferredName":"Low Grade Ductal Breast Carcinoma In Situ","longName":"3249014","preferredDefinition":"Ductal breast carcinoma in situ characterized by the presence of small, monomorphic neoplastic cells that form cribriform, micropapillary, or solid patterns. The nuclei are uniform and mitotic figures are rare.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ, Low Grade","conceptCode":"C9457","definition":"Breast ductal carcinoma in situ characterized by the presence of small, monomorphic neoplastic cells that form cribriform, micropapillary, or solid patterns. The nuclei are uniform and mitotic figures are rare.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-15A2-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A19C823-6F23-799A-E053-F662850A6C0A","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"ONEDATA","dateModified":"2019-05-30","deletedIndicator":"No"},{"value":"High","valueDescription":"High Grade Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"3249018","version":"1","preferredName":"High Grade Ductal Breast Carcinoma In Situ","longName":"3249018","preferredDefinition":"A ductal carcinoma in situ characterized by the presence of neoplastic cells with severe dysplasia and the formation of micropapillary, cribriform, or solid patterns. The nuclei show marked pleomorphism and have prominent nucleoli. Mitotic activity is usually present. There is comedo-type of necrosis present in the ducts. The necrotic debris is surrounded by pleomorphic malignant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ, High Grade","conceptCode":"C7949","definition":"Breast ductal carcinoma in situ characterized by the presence of neoplastic cells with severe dysplasia and the formation of micropapillary, cribriform, or solid patterns. The nuclei show marked pleomorphism and have prominent nucleoli. Mitotic activity is usually present. There is comedo-type of necrosis present in the ducts. The necrotic debris is surrounded by pleomorphic malignant cells.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-15EE-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A19C823-6F2E-799A-E053-F662850A6C0A","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"ONEDATA","dateModified":"2019-05-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6771220","version":"1","preferredName":"Ductal Breast Carcinoma In Situ Nuclear Grade Category","preferredDefinition":"A carcinoma entirely confined to the mammary ducts.  It is also known as DCIS.  There is no evidence of invasion of the basement membrane.  Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.:An evaluation of the size and shape of the nucleus in tumor cells and the percentage of tumor cells that are in the process of dividing or growing. Cancers with low nuclear grade grow and spread less quickly than cancers with high nuclear grade.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C2924:C18513:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Nuclear Grade","conceptCode":"C18513","definition":"An evaluation of the size and shape of the nucleus in tumor cells and the percentage of tumor cells that are in the process of dividing or growing. Cancers with low nuclear grade grow and spread less quickly than cancers with high nuclear grade.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A1A17E4-FE81-7986-E053-F662850A30EB","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"ONEDATA","dateModified":"2019-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A19C823-6F00-799A-E053-F662850A6C0A","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeDescription":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-30-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506112","version":"1","longName":"Breast","context":"MCL","ClassificationSchemeItems":[{"publicId":"6643181","version":"1","longName":"Initial Diagnosis","context":"MCL"}]},{"publicId":"5855817","version":"1","longName":"LabCAS","context":"MCL","ClassificationSchemeItems":[{"publicId":"6944398","version":"1","longName":"MCL PCA Pilot","context":"MCL"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"DCIS nuclear grade","type":"Preferred Question Text","description":"DCIS nuclear grade","url":null,"context":"MCL"}],"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A1DD4A5-0967-1496-E053-F662850AD292","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeDescription":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  10/14/19 jk classified for MCL PCA genomic pilot project.  5-30-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}